SEARCH

SEARCH BY CITATION

Keywords:

  • Diabetic rats;
  • Brain;
  • Fatty acids;
  • Cholesterol;
  • Lipid;
  • α-Lipoic acid;
  • Vitamin C;
  • Vitamin E

Abstract

The aim of this research was to examine the effects of a triple antioxidant combination (vitamins E (VE) and C (VC) plus α-lipoic acid (LA)) on the total lipid and cholesterol levels and the fatty acid composition of brain tissues in experimental diabetic and non-diabetic rats. VE and LA were injected intraperitoneally (50 mg/kg) four times per week and VC was provided as a supplement dissolved in the drinking water (50 mg/kg). In addition, rats in the diabetes 1 and D + VELAVC groups were given daily by subcutaneous insulin injections (8 IU/kg), but no insulin was given to rats in the diabetes 2 group.

The results indicate that the brain lipid levels in the D + VELAVC, diabetes 1 and diabetes 2 groups were higher than in the control group (P < 0.01). Total lipid was also higher in the non-diabetic rats treated with LA and VC. Total cholesterol was higher in the diabetes 1 and diabetes 2 groups (P < 0.05) than in controls. Cholesterol levels were similar in the D + VELAVC and LA groups but lower in the VC, VE and VELAVC groups of non-diabetic rats (P < 0.05 and P < 0.01). In respect of fatty acid composition, palmitic acid levels were lower in the diabetes 2 and non-diabetic VE groups than the control group (P < 0.05), but higher in the non-diabetic LA group (P < 0.05). Oleic acid (18:1 n-9) levels were lower in the diabetic and non-diabetic groups than the control group (P < 0.01), but higher in the non-diabetic LA group. Arachidonic acid (20:4 n-6) levels were similar in the diabetes 1, D + VELAVC and control groups (P > 0.05) but higher in the non-diabetic VE, VC, LA and VEVCLA groups (P < 0.05) and lower in the diabetes 2 group (P < 0.05). Docosahexaenoic acid (22:6 n-3) was elevated in the diabetes 2 and VEVCLA groups (P < 0.01, P < 0.05). In conclusion, the current study confirmed that treatment with a triple combination of VE, VC and LA protects the arachidonic acid level in the brains of diabetic and non-diabetic rats.